Artificial heart of Medicine of Pennsylvania State University (Penn State Hershey Medical Center) in Hershey, Pennsylvania; and AbioMed, Inc. of Danvers, Massachusetts. Despite considerable progress, the Cleveland program was discontinued after the first five years. Polymeric trileaflet valves ensure unidirectional blood flow with a low pressure gradient and good longevity. State-of-the-art transcutaneous energy transfer eliminates the need for electric wires crossing the chest wall. On July 19, 1963, E. Stanley Crawford and Domingo Liotta implanted the first clinical Left Ventricular Assist Device (LVAD) at The Methodist Hospital in Houston, Texas, in a patient who had a cardiac arrest after surgery. The patient
Progress in artificial intelligence the field is rarely credited for these successes. Kaplan and Haenlein structure artificial intelligence along three evolutionary stages: 1) artificial narrow intelligence – applying AI only to specific tasks; 2) artificial general intelligence – applying AI to several areas and able to autonomously solve problems they were never even designed for; and 3) artificial super intelligence – applying AI to any area capable of scientific creativity, social skills, and general wisdom. To allow comparison with human performance, artificial intelligence can be evaluated on constrained and well-defined problems. Such tests have been termed subject matter expert Turing tests. Also, smaller problems